Post by Viatris on X
Viatris@ViatrisInc
XToday we announced the filing of supplemental New Drug Applications to Japan's Ministry of Health, Labor and Welfare (MHLW) for the approval of EFFEXOR® for the treatment of Generalized Anxiety Disorder (GAD). Read for more information here: t.co
15 likes0 repliesPosted Apr 21, 2025